Transgen LLC is an R&D partner for companies and scientific teams that need reliable biotechnology solutions without having to build their own genetic engineering platform. We develop transgenic, reporter, and immortalized cell models, as well as producer strains for proteins and other organic molecules for biomedicine, industrial biotechnology, the food industry, and related fields.
Our key competence is taking on the complex engineering part of a project: from task analysis and genetic modification design to vector assembly, genome editing, generation of a stable cell line or strain, and confirmation of the target properties. This approach allows the customer to move faster from an idea to experimental testing, screening, validation, or scale-up, reducing R&D timelines, risks, and costs.
We work with human and animal cells, bacteria, and yeast. We perform gene knockouts, point substitutions, integration of sequences into specific loci, creation of reporter systems, inducible constructs, and producer cell lines. For projects where predictability and reproducibility are critical, we use controlled integration into Safe Harbor loci. When speed and efficiency are important, we use modern transgenesis systems, including Sleeping Beauty and PiggyBac. A separate area of our work is the immortalization of primary cells, which makes it possible to convert complex biological models into a convenient format for long series of experiments.
In industrial biotechnology, we help develop proprietary producer strains for target molecules: proteins, enzymes, vitamins, cofactors, and other valuable compounds. This is especially important at early stages, when a company needs to test a product hypothesis before making major investments in infrastructure and a team.
We offer several cooperation formats: turnkey development, a joint R&D project, or consulting with strategy design. At the outset, we prepare a technical project roadmap: a modification scheme, selection of the organism or cell model, risk assessment, timeline, budget, and success criteria. Our status as a small technology company confirms the maturity of our R&D base and the applied nature of our expertise. Transgen LLC is a team that turns a biological idea into a working model, cell line, or strain.
Our key competence is taking on the complex engineering part of a project: from task analysis and genetic modification design to vector assembly, genome editing, generation of a stable cell line or strain, and confirmation of the target properties. This approach allows the customer to move faster from an idea to experimental testing, screening, validation, or scale-up, reducing R&D timelines, risks, and costs.
We work with human and animal cells, bacteria, and yeast. We perform gene knockouts, point substitutions, integration of sequences into specific loci, creation of reporter systems, inducible constructs, and producer cell lines. For projects where predictability and reproducibility are critical, we use controlled integration into Safe Harbor loci. When speed and efficiency are important, we use modern transgenesis systems, including Sleeping Beauty and PiggyBac. A separate area of our work is the immortalization of primary cells, which makes it possible to convert complex biological models into a convenient format for long series of experiments.
In industrial biotechnology, we help develop proprietary producer strains for target molecules: proteins, enzymes, vitamins, cofactors, and other valuable compounds. This is especially important at early stages, when a company needs to test a product hypothesis before making major investments in infrastructure and a team.
We offer several cooperation formats: turnkey development, a joint R&D project, or consulting with strategy design. At the outset, we prepare a technical project roadmap: a modification scheme, selection of the organism or cell model, risk assessment, timeline, budget, and success criteria. Our status as a small technology company confirms the maturity of our R&D base and the applied nature of our expertise. Transgen LLC is a team that turns a biological idea into a working model, cell line, or strain.
Transgen LLC is an R&D partner for companies and scientific teams that need reliable biotechnology solutions without having to build their own genetic engineering platform. We develop transgenic, reporter, and immortalized cell models, as well as producer strains for proteins and other organic molecules for biomedicine, industrial biotechnology, the food industry, and related fields.
Our key competence is taking on the complex engineering part of a project: from task analysis and genetic modification design to vector assembly, genome editing, generation of a stable cell line or strain, and confirmation of the target properties. This approach allows the customer to move faster from an idea to experimental testing, screening, validation, or scale-up, reducing R&D timelines, risks, and costs.
We work with human and animal cells, bacteria, and yeast. We perform gene knockouts, point substitutions, integration of sequences into specific loci, creation of reporter systems, inducible constructs, and producer cell lines. For projects where predictability and reproducibility are critical, we use controlled integration into Safe Harbor loci. When speed and efficiency are important, we use modern transgenesis systems, including Sleeping Beauty and PiggyBac. A separate area of our work is the immortalization of primary cells, which makes it possible to convert complex biological models into a convenient format for long series of experiments.
In industrial biotechnology, we help develop proprietary producer strains for target molecules: proteins, enzymes, vitamins, cofactors, and other valuable compounds. This is especially important at early stages, when a company needs to test a product hypothesis before making major investments in infrastructure and a team.
We offer several cooperation formats: turnkey development, a joint R&D project, or consulting with strategy design. At the outset, we prepare a technical project roadmap: a modification scheme, selection of the organism or cell model, risk assessment, timeline, budget, and success criteria. Our status as a small technology company confirms the maturity of our R&D base and the applied nature of our expertise. Transgen LLC is a team that turns a biological idea into a working model, cell line, or strain.
Our key competence is taking on the complex engineering part of a project: from task analysis and genetic modification design to vector assembly, genome editing, generation of a stable cell line or strain, and confirmation of the target properties. This approach allows the customer to move faster from an idea to experimental testing, screening, validation, or scale-up, reducing R&D timelines, risks, and costs.
We work with human and animal cells, bacteria, and yeast. We perform gene knockouts, point substitutions, integration of sequences into specific loci, creation of reporter systems, inducible constructs, and producer cell lines. For projects where predictability and reproducibility are critical, we use controlled integration into Safe Harbor loci. When speed and efficiency are important, we use modern transgenesis systems, including Sleeping Beauty and PiggyBac. A separate area of our work is the immortalization of primary cells, which makes it possible to convert complex biological models into a convenient format for long series of experiments.
In industrial biotechnology, we help develop proprietary producer strains for target molecules: proteins, enzymes, vitamins, cofactors, and other valuable compounds. This is especially important at early stages, when a company needs to test a product hypothesis before making major investments in infrastructure and a team.
We offer several cooperation formats: turnkey development, a joint R&D project, or consulting with strategy design. At the outset, we prepare a technical project roadmap: a modification scheme, selection of the organism or cell model, risk assessment, timeline, budget, and success criteria. Our status as a small technology company confirms the maturity of our R&D base and the applied nature of our expertise. Transgen LLC is a team that turns a biological idea into a working model, cell line, or strain.